Cerenome (PSTV) Interest & Investment Income (2011 - 2026)
Plus Therapeutics (PSTV) posted quarterly Interest & Investment Income of $190000.0 for Q1 2026, up 18900.0% year-over-year from N/an in Q1 2025, and up 555.17% quarter-over-quarter from $29000.0 in Q4 2025.
Cerenome (PSTV) Interest & Investment Income (2011 - 2026) Analysis & Trends
Plus Therapeutics (PSTV) has reported Interest & Investment Income for 16 consecutive years, with $190000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest & Investment Income rose 18900.0% year-over-year to $190000.0; the TTM figure through Mar 2026 stood at $305000.0 (up 50.99% YoY), while the FY2025 annual figure was $116000.0, down 57.51% from the prior year.
- Interest & Investment Income rose to $190000.0 in Q1 2026 per PSTV's latest filing, from $29000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $190000.0 in Q1 2026 and bottomed at $1000.0 in Q1 2025.
- Historically, Interest & Investment Income has averaged $66235.3 across 5 years, with a median of $59000.0 in 2025.
- Annual changes were most pronounced in 2025 — Interest & Investment Income tumbled 98.61% — and 2026, when it surged 18900.0%.
- Plus Therapeutics' Interest & Investment Income stood at $73000.0 in 2022, then surged by 50.68% to $110000.0 in 2023, then sank by 50.91% to $54000.0 in 2024, then tumbled by 46.3% to $29000.0 in 2025, then surged by 555.17% to $190000.0 in 2026.
- Business Quant data shows PSTV's Interest & Investment Income at $190000.0 in Q1 2026, $29000.0 in Q4 2025, and $59000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 67.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 27.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 28.14 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 115.94 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 10.98 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 5.13 Mn |
| 10 | Cerenome | 28.07 Mn | 19.48 Mn | - | 56,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 190,000.00 |
| Dec 31, 2025 | 29,000.00 |
| Sep 30, 2025 | 59,000.00 |
| Jun 30, 2025 | 27,000.00 |
| Mar 31, 2025 | 1,000.00 |
| Dec 31, 2024 | 54,000.00 |
| Sep 30, 2024 | 80,000.00 |
| Jun 30, 2024 | 67,000.00 |
| Mar 31, 2024 | 72,000.00 |
| Dec 31, 2023 | 110,000.00 |
| Sep 30, 2023 | 119,000.00 |
| Jun 30, 2023 | 120,000.00 |
| Mar 31, 2023 | 51,000.00 |
| Dec 31, 2022 | 73,000.00 |
| Sep 30, 2022 | 48,000.00 |
| Jun 30, 2022 | 19,000.00 |
| Mar 31, 2022 | 7,000.00 |
| Dec 31, 2021 | 6,000.00 |
| Sep 30, 2021 | 5,000.00 |
| Jun 30, 2021 | 4,000.00 |